The European Court of Auditors has warned that Europe still lacks a reliable system to prevent and manage medicine shortages, ...

Danish pharma major Novo Nordisk (NOV: N) has reported positive Phase III data for its experimental oral version of Wegovy (semaglutide), showing weight-loss benefits close to those of the already ...

A life-sciences startup based in South San Francisco, focused on developing bispecific antibodies for immune and inflammatory diseases.

Prota Therapeutics, an Australian biotech developing novel oral immunotherapy treatments that induce remission of allergy, ...

Spanish biotech ARTHEx has closed an expanded series B financing round totaling $87 million, led by French state-backed ...

South Korean biotech Alteogen (KOSDAQ:196170) has secured European Commission clearance for Eyluxvi (ALT-L9), its biosimilar ...

Belgian biopharma UCB has announced three-year data from the BE HEARD trials for Bimzelx (bimekizumab) in moderate to severe ...

Indian drugmakers are urging the government to ensure generic drugs are excluded from an ongoing US investigation, warning ...

Ollin Biosciences has officially launched with $100 million in funding to advance a pipeline of therapies for ...

Denmark’s ALK-Abelló has entered into a partnership agreement with China-based Changchun GeneScience Pharmaceutical (GenSci) ...

US drug developer Oruka Therapeutics’ shares leapt as much as 20% in early trading, after it announced positive data from its ...

Switzerland-based Roivant and Priovant Therapeutics today announced positive results from the Phase III VALOR study ...